Steam-Mixed Powder Inhaler for Lung Delivery Without Drug Loss
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Conventional powder inhalers fail to ensure that a sufficient amount of particulate drug reaches the lungs of patients with asthma or coronavirus, often causing drug loss within the device and excessive inhalation.
Innovation Solution
A drug vaporization and inhalation device that mixes particulate drugs with vaporized steam using a vaporization container, inducing material, fine particle vaporizer, and a cap with blades to ensure the drug reaches the lungs without loss.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional powder inhalers spray out powdered drug, then the device structure is simple, but the drug cannot sufficiently arrive at patient's lungs causing drug loss
Solution Approach 1:
The patent transforms the drug delivery system from solid powder to vapor phase by heating the inhalation powder in a vaporization chamber. The heated powder undergoes phase transition to form vapor that is then delivered to the patient's lungs through a mouthpiece, ensuring complete drug delivery without residue loss in the device.
Solution Approach 2:
The patent replaces the conventional mechanical spray mechanism with a thermal vaporization system. Instead of using mechanical force to spray powder, the system uses heat to vaporize the powder, eliminating the need for complex spray nozzles and mechanical actuators while improving drug delivery reliability.
2Ease of manufacture
If conventional inhalers use excipient to dilute active material, then the manufacturing process is simple, but the excipient influences the characteristics of inhalation powder
Solution Approach 1:
The patent removes the excipient component from the inhalation powder formulation. By using pure active material without diluents, the system eliminates the manufacturing complexity associated with selecting and controlling excipient particle sizes while maintaining ease of manufacture through direct vaporization of the active substance.
3Loss of substance
If conventional inhalers allow powder to remain in the device, then the device structure is simple, but infected patients may excessively inhale the drug
Solution Approach 1:
The vaporization process ensures complete drug delivery by transforming the powder to vapor phase, which is then fully inhaled by the patient. This phase transition eliminates drug residue in the device chamber, preventing both drug loss and subsequent excessive inhalation from remaining powder.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The device effectively delivers the particulate drug to the lungs by mixing it with vaporized steam, preventing drug loss and excessive inhalation.
Implementation Method 1
an inducing material disposed under the vaporization container to be inserted into the first storage space to induce the vaporization promoting composition stored in the first storage space to be discharged by means of a capillary action
Implementation Method 2
a fine particle vaporizer heated when power is supplied thereto to vaporize the vaporization promoting composition induced by the inducing material
Implementation Method 3
blades protruding downward from the inner bottom thereof to incise the capsule placed in the capsule accommodation portion
Implementation Method 4
so that the vaporized steam or the powdered drug discharged from the capsule and mixed with the vaporized steam guided by the second guide paths is inhaled through the inhalation pipe
Data Source
AI summary
Provided is a drug vaporization and inhalation device. The drug vaporization and inhalation device is configured such that when a user inhales a particulate drug, the drug is contained in vaporized steam, and therefore, the drug can sufficiently arrive at the lungs of the user, without loss, thereby preventing a given amount of the drug from remaining in an inhalation container and improving the drug inhalation efficiency of the user along with prevention of excessive inhalation of the drug.


